Bio-Techne Corp (STU:TE1)
€ 69.5 0 (0%) Market Cap: 11.07 Bil Enterprise Value: 11.27 Bil PE Ratio: 80.74 PB Ratio: 5.63 GF Score: 95/100

Bio-Techne Corp at Barclays Global Healthcare Conference Transcript

Mar 16, 2022 / 12:30PM GMT
Release Date Price: €94 (+6.82%)
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

All right. Good morning, everybody. I'm Luke Sergott. I cover life science tools and diagnostics here at Barclays. It's my pleasure here to introduce Chuck Kummeth, CEO of Bio-Techne. Known each other for a long time, and thank you for joining us here first in person down in Miami.

Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director

Good place to start getting out.

Questions & Answers

Luke England Sergott;Charles R. Kummeth
Barclays Bank PLC, Research Division - Research Analyst;Bio-Techne Corporation -

That's right. Right. All right. Well, so I guess we could kick it off. I've been starting everything, all these sessions with the macro. I know that there's limited exposure here from Russia and Ukraine, but are you guys -- just talk about demand trends within Europe that you're seeing. Any spillover? Any slowing of orders or anything like that across any of your end markets?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot